Hypromellose
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11075 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hepatic veno-occlusive disease-immunodeficiency syndrome | KG + DL |
| 2 | pancytopenia due to IKZF1 mutations | KG + DL |
| 3 | hepatic veno-occlusive disease | KG + DL |
| 4 | combined immunodeficiency due to CRAC channel dysfunction | KG + DL |
| 5 | absent thumb-short stature-immunodeficiency syndrome | KG + DL |
| 6 | facial dysmorphism-immunodeficiency-livedo-short stature syndrome | KG + DL |
| 7 | immuno-osseous dysplasia | KG + DL |
| 8 | psoriasis | KG + DL |
| 9 | autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis | KG + DL |
| 10 | human herpesvirus 8-related tumor | KG + DL |
| 11 | middle ear neuroendocrine tumor | KG + DL |
| 12 | hepatic infarction | KG + DL |
| 13 | primary immunodeficiency due to a defect in adaptive immunity | KG + DL |
| 14 | paroxysmal nocturnal hemoglobinuria | KG + DL |
| 15 | mixed-type autoimmune hemolytic anemia | KG + DL |
| 16 | peliosis hepatis | KG + DL |
| 17 | malignant cutaneous granular cell skin tumor | KG + DL |
| 18 | ectomesenchymoma | KG + DL |
| 19 | drug-induced autoimmune hemolytic anemia | KG + DL |
| 20 | dermatitis | KG + DL |
| 21 | prostatic urethra urothelial carcinoma | KG + DL |
| 22 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 23 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 24 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 25 | proteinuria | KG + DL |
| 26 | transitional cell carcinoma | KG + DL |
| 27 | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | KG + DL |
| 28 | syndrome with combined immunodeficiency | KG + DL |
| 29 | neonatal autoimmune hemolytic anemia | KG + DL |
| 30 | hydroa vacciniforme, familial | KG + DL |
| 31 | pityriasis lichenoides | KG + DL |
| 32 | primary CD59 deficiency | KG + DL |
| 33 | acne keloid | KG + DL |
| 34 | amyopathic dermatomyositis | KG + DL |
| 35 | cold agglutinin disease | KG + DL |
| 36 | neonatal dermatomyositis | KG + DL |
| 37 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 38 | acrodermatitis chronica atrophicans | KG + DL |
| 39 | parapsoriasis | KG + DL |
| 40 | liver angiosarcoma | KG + DL |
| 41 | psoriasis 14, pustular | KG + DL |
| 42 | cutaneous neuroendocrine carcinoma | KG + DL |
| 43 | pyogenic autoinflammatory syndrome | KG + DL |
| 44 | oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies | KG + DL |
| 45 | oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies | KG + DL |
| 46 | unclassified autoinflammatory syndrome | KG + DL |
| 47 | acute lichenoid pityriasis | KG + DL |
| 48 | granulomatous autoinflammatory syndrome | KG + DL |
| 49 | pustulosis palmaris et plantaris | KG + DL |
| 50 | Budd-Chiari syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.